Skip to main content
Clinical Trials/NCT02560571
NCT02560571
Unknown
Phase 2

Preoperative Evaluation of Endometrial Cancer

Meir Medical Center1 site in 1 country200 target enrollmentOctober 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Endometrial Cancer
Sponsor
Meir Medical Center
Enrollment
200
Locations
1
Primary Endpoint
number of participants with positive nodes
Last Updated
9 years ago

Overview

Brief Summary

The study evaluates pre-operative prediction of the risk for lymph nodes involvement in endometrial cancer patients. Patients will undergo ultrasound exam (bi and three dimensional) and biomarker test - Ca 125, in addition to routine physical and laboratory exams, before surgery.

The sonographic evaluation will include endometrial characteristics and myometrial invasion, pelvic findings and enlarged lymph nodes.

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
October 2020
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yfat kadan

Dr

Meir Medical Center

Eligibility Criteria

Inclusion Criteria

  • Endometrial cancer patients
  • Surgical candidates

Exclusion Criteria

  • Fertility preservation therapy
  • Contraindication for surgery
  • Stage 2 and higher

Outcomes

Primary Outcomes

number of participants with positive nodes

Time Frame: 4 weeks after surgery (4-6 weeks from enrollment)

Study Sites (1)

Loading locations...

Similar Trials